iData Insights

Global Alzheimer s Drug Market: Trends, Opportunities and Forecasts (2015-2020) Now Available at iData Insights

Press Release   •   Jan 14, 2016 13:19 IST

Executive Summary Progressive numbers of neurological disorders along with escalating demand for drugs to control of Alzheimer Disease. The Global Alzheimer s Market is growing at a moderate rate over last five years on account of rising expenditure on health care especially neurological disorders among ageing population and escalating role of private and government bodies in empowering R&D measures to avoid degenerative disorders. During 2015-20, Global Alzheimer Disease Market is anticipated to grow at an increased rate on account of robust expansion plans of the increase in medical facilities. Moreover, increase in number of patients suffering from degenerative disorder is further anticipated to boost the Global Alzheimer s market in the coming years. According to Azoth Analytics research report,  Global Alzheimer s Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age:65 years; By Region; Global Dementia Market) , global Alzheimer s market is projected to exhibit a CAGR of over 8.54% during 2015 2020. On the basis of Reisberg Scale, market is categorized by seven stages of Alzheimer. Alzheimer is expected to be cured by Drugs; Exercise and Nutrition. Growth in Alzheimer s Drug market is anticipated to grow in the next five years. Asia Pacific region dominated the revenue contribution share in 2014 and the region is forecast to continue its domination through 2020. Few of the leading companies operating in Global Alzheimer s Disease Market include Axovant Sciences Ltd., Biotie Therapies, Acadia Pharmaceuticals, Novartis International AG and many more. Scope of the Report The report  Global Alzheimer s Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age:65 years; By Region; Global Dementia Market) analyzes the following aspects of global Alzheimer s market: " Global Alzheimer s Market Size, Share & Forecast " Segmental Analysis  By Therapeutics, By Diagnostics and Biomarkers, By Imaging Sector, By Patient and By Drugs " Policy & Regulatory Landscape " Market Entry Strategies for Domestic/Foreign Players " Changing Market Trends & Emerging Opportunities " Competitive Landscape & Strategic Recommendations Why You Should Buy This Report? 1. To gain an in-depth understanding of Alzheimer disease and dementia market propelling globally. 2. To identify the on-going trends and anticipated growth in the next five years 3. To help industry consultants, drug and diagnostics manufacturers, vendors and dealers align their market-centric strategies 4. To obtain research based business decision and add weight to presentations and marketing material 5. To gain competitive knowledge of leading players 6. To avail limited customization in the report without any extra charges and get research data or trends added in the report as per the buyer s specific needs.

Browsewith TOC @

To Get Sample Copy of Report visit @

Table of Contents

1. Research Methodology

2. Alzheimer s Disease Market Overview

3. Global Alzheimer s Disease Market Outlook

4. Global Alzheimer s Disease Market

4.1 By Therapeutics

4.2 By Diagnostics and Biomarkers

4.3 By Imaging Sector

4.4 By Disease Modifying Therapeutics

5. Global Alzheimer s Disease Market Outlook-By Demographic (Age-Group)

6. Global Alzheimer s Disease Market Outlook-By Drug

7. Global Alzheimer s Disease Market Outlook-By Region

8. United States Alzheimer s Disease Market Outlook

8.1 United States Dementia Market Outlook

9. Global Dementia Disease Market Outlook

10. Global Dementia Disease Market Outlook

10.1 By Regional Break-Up

10.1.1 Asia-Pacific Dementia Market Outlook

10.2 By Countries

10.2.1 Low Income Country -wise Break up

10.2.2 Top Ten Country-wise Break-Up

Australia Dementia Market Outlook

UK Dementia Market Outlook

11. Market Dynamics

11.1 Drivers

11.2 Challenges

12. Market Trends & Developments

13. Competitive Landscape

13.1 Sales Comparatives, Top 5 Companies

13.2 EBITDA Comparatives, Top 5 Companies

13.3 EBIT Comparatives, Top 5 Companies

13.4 PBT Comparatives, Top 5 Companies

13.5 PAT Comparatives, Top 5 Companies

13.6 Current Ratio Comparatives, Top 5 Companies

14. Company Profiling

14.1 Pfizer Inc.

14.2 Novartis International AG

14.3 Axovant Sciences Ltd.

14.4 Acadia Pharmaceuticals

14.5 Biotie Therapies

Read More

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

iData Insights

Tel: 1-866-237-2965


AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects